Home » Posts tagged with » Sharon Chen
F2G gets olorofim breakthrough therapy status from FDA for mold infection
F2G has secured breakthrough therapy designation to olorofim (formerly F901318) from the US Food and Drug Administration (FDA) for the treatment of invasive mold infections. The breakthrough therapy designation is for the use of olorofim in patients having limited or no treatment options, and also those who are intolerant to currently available therapy for their […]
Business News Today
- Triton Knoll offshore wind farm : Partrac to supply metocean buoys
- Aker, EDP to develop 500MW floating wind farm in South Korea
- Vale to sell stake in Henan Longyu Energy Resources to Yongmei
- Astellas Pharma acquires US biotech company Xyphos Biosciences
- Adelphia Gateway pipeline conversion project approved by FERC
- Al-Zour oil refinery project : COOEC-Fluor JV wraps up module program
- Allergan bags Ubrelvy FDA approval for migraine treatment
- Micro Labs, Mylan secure FDA approval for first generics of Eliquis
- LG Electronics to unveil indoor gardening appliance at CES 2020, Las Vegas
- Arcadis Ost 1 offshore windfarm : MHI Vestas to supply V174-9.5MW turbines
